From a therapeutic point of view, the fact that PTHrP is able to regulate EMT‐induced CSC phenotype in breast cancer suggests it is a valuable therapeutic target for preventing recurrence and metastasis, although further studies will be needed for confirmation. Here, PTHLH is linked to breast cancer.